Fundraising FoxSolas BioVentures — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.
BiotechDigital HealthHealthtechMedical DevicesCary, US
Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)inRichard Shea(Executive Officer, Director, Promoter)in
BoardHannah Chang(Director)Aiden Aceves(Director)in
Co-investorsARCH Venture PartnersInsight PartnersBroadview VenturesMedbluePlatanus VenturesRev1 Ventures+1 more
Knopp Biosciences is a privately held company that manages a portfolio of future milestone payments and product royalties from drug pipelines it sold or spun off in 2022.
BiotechHealthtechPittsburgh, US
Thomas V. Petzinger, Jr.(LLC Manager)Michael E. Bozik(LLC Manager)Steven Dworetzky(Executive Officer)
BoardBenjamin A. Gomez(LLC Manager)Jeffrey S. McCormick(LLC Manager)inGregory T. Hebrank(LLC Manager)
Co-investorsSaturn Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.